Integration of VR and AR Dementia Prevention Health Education Progrom for Older Adults With Mild Cognitive Impairment
Integration of VR, AR, AI and Wearable Technology to Develop Innovative Health Education and Monitoring Systems on Symptom Management, Situational Reaction, Learinging Process and Physical and Psychological Health of Early Dementia
1 other identifier
interventional
139
1 country
1
Brief Summary
The goal of this randomized controlled trial is to evaluate the effectiveness of Virtual Reality (VR)-based cognitive health education for older adults with mild cognitive impairment (MCI) in Taiwan. The study aims to assess whether VR-supported interventions improve cognitive health knowledge, health literacy, and self-management skills among participants. The primary research questions are:
- 1.Does the VR-based intervention enhance participants' knowledge related to dementia and their health literacy?
- 2.Does the VR-based intervention improve cognitive function, mental well-being, and self-efficacy compared to a control group?
- 3.Intervention group: This group will receive the "VR Dementia Prevention Health Education Module," an immersive virtual reality program designed to enhance dementia-related knowledge and coping strategies.
- 4.Control group: This group will receive standard, routine health education without VR exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2025
CompletedFebruary 19, 2026
February 1, 2026
7 months
March 11, 2025
February 18, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Dementia-Related Knowledge
Dementia-related knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS), a validated tool for evaluating comprehensive understanding of dementia. The DKAS includes 25 true/false items and provides an additional "Don't Know" response option to reduce guessing.
Baseline (Day 0, prior to intervention start) Immediate Post-Intervention (Day 0, following completion of the VR session, approximately 2 hours after Baseline assessment) Follow-up (Month 3, 12 weeks post-intervention, to assess retention effects)
Change in Health Literacy
Health literacy concerning dementia prevention will be evaluated using the Dementia Health Literacy Scale (DHLS). The DHLS includes 20 items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). This scale features three subdomains: Functional Health Literacy (8 items) - Evaluates the ability to manage dementia-related information for daily needs; Communicative Health Literacy (5 items) - Assesses skills in accessing, understanding, and applying dementia-related health information during interactions; and Critical Health Literacy (7 items) - Gauges higher-order cognitive skills and the ability to critically analyze dementia-related health information.
Baseline (Day 0, prior to intervention start) Immediate Post-Intervention (Day 0, following completion of the VR session, approximately 2 hours after Baseline assessment) Follow-up (Month 3, 12 weeks post-intervention, to assess retention effects)
Secondary Outcomes (2)
Change in Self-Efficacy Related to Dementia Prevention
Baseline (Day 0, prior to intervention start) Immediate Post-Intervention (Day 0, following completion of the VR session, approximately 2 hours after Baseline assessment) Follow-up (Month 3, 12 weeks post-intervention, to assess retention effects)
Change in Attitudes Toward Dementia
Baseline (Day 0, prior to intervention start) Immediate Post-Intervention (Day 0, following completion of the VR session, approximately 2 hours after Baseline assessment) Follow-up (Month 3, 12 weeks post-intervention, to assess retention effects)
Study Arms (2)
Experimental Group (VR Dementia Prevention Education)
EXPERIMENTALParticipants in this arm will take part in the VR Dementia Prevention Health Education Module, an immersive virtual reality (VR) intervention aimed at enhancing dementia-related knowledge, health literacy, self-efficacy, and attitudes toward dementia. The intervention combines 360-degree panoramic VR technology with interactive educational content to create a realistic and engaging learning experience for older adults with mild cognitive impairment (MCI).
Control Group (No Intervention)
NO INTERVENTIONParticipants in this arm will not receive any active intervention during the study. They will continue with their usual daily routine, without exposure to VR-based health education or any structured dementia-related educational programs. This group serves as a comparison to evaluate the effects of the VR Dementia Prevention Health Education Module administered to the experimental group.
Interventions
A virtual reality (VR) cognitive health education program designed to enhance knowledge related to dementia, improve health literacy, boost self-efficacy, and shape attitudes towards dementia. Participants engage with 360-degree immersive VR modules using VR headsets that simulate real-world scenarios related to dementia. The intervention comprises five interactive VR sessions, each addressing important topics in dementia prevention and management. Trained research staff will guide participants to ensure safe and effective interaction with the VR system.
Eligibility Criteria
You may qualify if:
- Adults aged 65 years and older.
- AD-8 score of 2 or higher, indicating possible cognitive impairment.
- Ability to understand and follow basic instructions in Mandarin or Taiwanese.
- Capacity to provide informed consent or have a legally authorized representative to provide consent.
- Ability to tolerate and interact with VR equipment (e.g., wearing a VR headset, using hand controllers).
You may not qualify if:
- Diagnosed with moderate to severe dementia (i.e., unable to follow basic instructions).
- Presence of severe visual, auditory, or motor impairments that hinder interaction with VR devices.
- Diagnosed with severe psychiatric disorders (e.g., schizophrenia, major depressive disorder).
- Unable to communicate effectively in Mandarin or Taiwanese.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan Normal University
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2025
First Posted
March 21, 2025
Study Start
September 30, 2024
Primary Completion
May 8, 2025
Study Completion
August 10, 2025
Last Updated
February 19, 2026
Record last verified: 2026-02